for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

For the first time in over 25 years (since the approval of oxybutynin in 1972), better medications are available for the overactive bladder. With the recent approval of tolterodine and oxybutynin ...

"It works like magic," says Namazzi. "Parasite clearance was very fast [compared to other malaria medications]. It had less complications. The mortality was lower." But lately, that magic hasn't ...

Symptoms can range from acute (short-term) mania to depression and depressive episodes. Luckily, multiple treatments exist that can help you manage the condition. Medications such as mood stabilizers, ...

According to the National Institute of Mental Health (NIMH), more than one in five adults (about 20%) in the United States has a mental health condition. Treatments for mental health conditions are ...

After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin ...

Oct. 9, 2024 — A new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. Types of cancers found to have a small increased ...

After hours: November 15 at 7:55 PM EST Loading Chart for DRUG ...